178
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Alloimmunization to Rh Antigen (D, C, E, C, E) Among Pregnant Women Attending Antenatal Care in South Western Uganda

ORCID Icon, , ORCID Icon, , &
Pages 747-752 | Received 10 Sep 2022, Accepted 18 Nov 2022, Published online: 29 Nov 2022

References

  • Rudman SV. Textbook of Blood Banking and Transfusion Medicine. 2nd ed. Elsevier Saunders; 2005.
  • Reid ME, Lomas-Francis C, Olsson ML. RH - Rh Blood Group System, in the Blood Group Antigen FactsBook. 3rd. Boston: Academic Press; 2012:147–262.
  • Gupta GK, Balbuena-Merle R, Hendrickson JE, et al. Immunohematologic aspects of alloimmunization and alloantibody detection: a focus on pregnancy and hemolytic disease of the fetus and newborn. Transfus Apher Sci. 2020;59(5):102946. doi:10.1016/j.transci.2020.102946
  • Das S, Shastry S, Rai L, et al. Frequency and clinical significance of red cell antibodies in pregnancy – a prospective study from India. Indian J Pathol Microbiol. 2020;63(2):241–246. doi:10.4103/IJPM.IJPM_737_19
  • Habiba U, Munir A, Waris S, et al. Frequency and types of red cell alloantibodies in pregnant females. In Proc. 2020;34:21–25.
  • Makroo RN, Bhatia A, Gupta R, et al. Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population. Indian J Med Res. 2013;137(3):521–526.
  • Mbalibulha Y, Natukunda B, Livex OA, et al. ABO and rh antigen distribution among pregnant women in South Western Uganda. J Blood Med. 2022;13:351–355. doi:10.2147/JBM.S360769
  • Hoffbrand AV, Daniel C, Edward GD. Post Graduate Hematology. John Wiley & Sons; 2005:271.
  • Ainley L, Jardim JR, Tan J, et al. Prevalence of maternal alloantibodies in a large teaching hospital and their impact on outcomes of fetuses/neonates. Transfus Med. 2017;27(3):228–230. doi:10.1111/tme.12399
  • Jeremiah ZA, Mordi A, Buseri FI, Adias TC. Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria. Immunohematology. 2011;5:39–41.
  • Bondagji NS. Rhesus alloimmunization in pregnancy. A tertiary care center - Experience in the Western region of Saudi Arabia. Saudi Med J. 2012;33:688.
  • Sahoo BB, Mishra MS, Mishra D, Panigrahy R, Parida P. Prevalence of red cell alloantibodies in pregnant women. Haematol Int J. 2020;4(1):1–9.
  • Kahar M. Frequency of red cell alloantibodies in pregnant females of navsari district: an experience that favours inclusion of screening for irregular erythrocyte antibody in routine antenatal testing profile. J Obstet Gynaecol India. 2018;68(4):300–305. doi:10.1007/s13224-017-0984-5
  • Li S. Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management. BMC Pregnancy Childbirth. 2020;20(1):539. doi:10.1186/s12884-020-03235-w
  • Koelewijn JM, Slootweg YM, Folman C, et al. Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies. Transfusion. 2020;60(2):391–399. doi:10.1111/trf.15631
  • Filbey D, Hanson U, Wesström G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta Obstet Gynecol Scand. 1995;74(9):687–692. doi:10.3109/00016349509021175
  • Mangwana S, Simon N, Sangwan L. RH phenotype, ABO and kell antigens, alleles and haplotypes frequencies in North Indian blood donor population. Glob J Transfus Med. 2021;6(1):81.
  • Dholakiya SK, Bharadva S, Vachhani J, et al. Red cell alloimmunization among antenatal women attending tertiary care center in Jamnagar, Gujarat, India. Asian J Transfus Sci. 2021;15(1):52. doi:10.4103/ajts.AJTS_72_17
  • Mayer B, Hinkson L, Hillebrand W, et al. Efficacy of antenatal intravenous immunoglobulin treatment in pregnancies at high risk due to alloimmunization to red blood cells. Transfus Med Hemotherapy. 2018;45(6):429–436. doi:10.1159/000490154
  • Moinuddin I, Millward FC, Millward P. Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan. J Blood Med. 2019;2019(10):283–289. doi:10.2147/JBM.S214118
  • Moise K. Management of pregnancy complicated by Rhesus (D) alloimmunization; 2016:3.
  • Mukhtar I, Abdulkadir A. Frequencies of ABO and Rhesus (D) blood group phenotypes among pregnant women attending antenatal clinic at Murtala Muhammad Specialist Hospital, Kano, Nigeria. J Med Trop. 2019;21(1):31–36. doi:10.4103/jomt.jomt_4_19
  • Ghesquière L, Garabedian C, Coulon C, et al. Management of red blood cell alloimmunization in pregnancy. J Gynecol Obstet Hum. 2018;47(5):197–204. doi:10.1016/j.jogoh.2018.02.001
  • Lurie S, Eliezer E, Piper I, et al. Is antibody screening in Rh (D)-positive pregnant women necessary? J Matern Fetal Neonatal Med. 2003;14(6):404–406. doi:10.1080/14767050412331312260
  • Adeniji AA, Fuller I, Dale T, et al. Should we continue screening rhesus D positive women for the development of atypical antibodies in late pregnancy? J Matern Fetal Neonatal Med. 2007;20(1):59–61. doi:10.1080/14767050601123317
  • Mbalibulha Y, Natukunda B, Mugyenyi G, et al. Occurrence of anti-D alloantibodies among pregnant mothers in Kasese District, Western Uganda. J Blood Med. 2015;6:125–129. doi:10.2147/JBM.S80977
  • Pahuja S, Gupta SK, Pujani M, et al. The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi. Blood Transfus. 2011;9(4):388–393. doi:10.2450/2011.0050-10
  • Etura JE, Amaechi RA, Akpotuzor JO, et al. Demographics of rhesus phenotype of blood donors in Calabar: a case study of University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria. Adv Hematol. 2020;2020:2659398. doi:10.1155/2020/2659398